Background: Endoscopic endonasal dacryocystorhinostomy (EnDCR) offers a minimally invasive alternative to external DCR for nasolacrimal duct obstruction, with ongoing debate over stenting efficacy. This study compares outcomes of EnDCR with prolene stenting versus no stenting and evaluates prolene as a cost-effective alternative to silicone. Methods: In this prospective observational study at MNR Medical College Hospital over one year, 50 patients with chronic dacryocystitis (CDC), mucocele, or pyocele due to nasolacrimal obstruction were randomly allocated (simple randomization, computer-generated) into two groups of 25: Group A (EnDCR with prolene stent, removed at 6 weeks) and Group B (EnDCR without stent). Inclusion: recurrent epiphora/CDC with confirmed obstruction. Exclusions: non-NLD causes, trauma/tumors, uncontrolled comorbidities, unfit/unwilling patients, revisions. Preoperative: ophthalmic/ENT exam, probing, nasal endoscopy. Postoperative: 3-month follow-up assessing symptomatic relief (epiphora grading 0-3; success: ≤2) and anatomical patency (syringing). Analyzed via SPSS v16 (t-tests, Fisher's exact; p<0.05 significant). Results: Mean age 49.18 years; 82% female; 52% left-sided. At 3 months, Group A success: 92% (23/25 patent, relieved); Group B: 88% (22/25). No significant intergroup difference (p=0.999). Complications minimal: minor bleed (12%), irritation/granulation (8%), rhinostomal issues (6%); no major events. Conclusion: EnDCR yields high success (88-92%) with/without prolene, supporting its safety, efficacy, and cosmetic advantages. Prolene proves viable, economical stenting in resource-limited settings.
Total tooth loss or edentulism is a severe oral disorder, most common in the aged, and impacts general quality of life by disturbing chewing, speech, and appearance [1]. Complete dentures remain the most sought-after prosthetic treatment among totally edentulous individuals and provide functional and psychological rehabilitation [2]. Complete denture adaptation is often inadequate as primary wearers experience discomfort, mastication difficulty, excess salivary flow, speech disturbance, and psychological morbidity [3]. Individual adaptation is a dynamic process and is influenced by the age, gender, oral anatomy, neuromuscular coordination, and previous experience of the individual with dentures [4].
The comfort and satisfaction of complete denture wearers are determined by a variety of factors like the fit, occlusion, and retention of the prosthesis, as well as patient-related factors including pain tolerance, motivation, and adaptability [5]. Studies have shown that initial discomfort is normal, but adaptation tends to be progressive after a few weeks to months [2, 6]. Chewing efficiency and intelligible speech improve with time, and overall comfort and satisfaction are achieved [7]. Despite advancements in prosthodontics, a large number of patients who are wearing dentures for the first time have trouble adapting, and this causes frustration and even abandonment of the prosthesis [8]. It is critical that prosthodontists have an understanding of the adaptation process to improve their ability to educate their patients, develop better treatment planning, and produce superior long-term results [9].
High levels of older persons require complete dentures due to untreated oral infections, periodontal disease, and the scarcity of dental treatment in Bangladesh [10]. However, limited studies exist assessing the adaptation and comfort of novice complete denture wearers in the Bangladeshi population [11]. Cultural and dietary lifestyles, oral hygiene behavior, and access to healthcare contribute to the acceptance and success of dentures, and thus it is important to investigate patient experiences in this regard [12, 13].
The current study aimed to evaluate first-time complete denture wearers' adaptation process and comfort levels over a six-month period. By measuring patient-reported difficulties, adaptation time, and satisfaction, the study seeks to have an understanding of denture wearers' current difficulties and factors for successful adaptation. Findings can be used to improve prosthetic rehabilitation strategies and patient counseling, which will enhance the quality of edentulous patients' lives in Bangladesh.
Study Design: Prospective observational study. Study area: MNR medical college and hospital, Fasalwadi, Sangareddy , ENT OPD. Study Period: one year. Sample size: The study consisted of a total of 50 subjects. The sample size for the present study was estimated based on the study conducted by Shah et al10 where success rate for patients with placement of stent was 91.66% using this parameter sample size for the study was calculated using the formula Z at 95% CI = 1.96 P = 91.6% Loss to follow up = 10% D= 8% Using this the sample size was estimated to be 50 Sampling Technique: Simple random sampling method. Inclusion Criteria: All patients with recurrent epiphora or dacryocystitis and have been diagnosed to have nasolacrimal duct obstruction not fulfilling the exclusion criteria. Exclusion Criteria: 1. Watering due to causes other than the naso lacrimal duct obstruction 2. Patients with lacrimal trauma or lacrimal sac tumours. 3. Patients with uncontrolled hypertension and diabetes mellitus. 4. Patients unwillingness for EnDCR surgery and those who are not fit for surgery 5. Revision EnDCR and failed external dacryocystorhinostomy. Ethical consideration: Institutional Ethical committee permission was taken before the commencement of the study. Methods of Data Collection: The present study is a prospective study where 50 patients with recurrent epiphora or dacryocystitis and have been diagnosed to have nasolacrimal duct obstruction were included. Informed consent was taken from all the study participants. Study included fifty patients, divided into two groups of 25 patients each. Group A consists of patients who underwent endoscopic DCR with silicon stent and group B consists of patients who underwent endoscopic DCR without stent Preoperative evaluation: The pre-operative evaluation consisted of a standard ophthalmic and otolaryngologic examination, lacrimal probing followed by irrigation and Nasal Endoscopy. The nasal cavity was examined and the need for additional nasal surgery (i.e., septoplasty, middle turbinate reduction) also was determined pre-operatively. Randomization of patients into two groups was done on the basis of simple randomization technique by computer generated token system after their Pre-anesthetic checkup. 25 patients underwent endoscopic DCR with Prolene stenting and 25 without stenting Postoperative care and follow up: Broad-spectrum oral antibiotics were given for 5 days together with Ofloxacin eyedrops for 7 days. Nasal saline drops were also prescribed after pack removal for 4 weeks. All patients were followed up till 3rd month Post operatively Prolene stent was removed at 6 weeks. At every visit resident assessed subjective symptom of epiphora as No epiphora (0), Minimal epiphora (1), Moderate epiphora (2) and Severe epiphora (3), Grade 0, 1 and 2 were classified as success and 3 as a complete failure. While anatomical patency was assessed by lacrimal syringing under endoscopic guidance as patent and not patent. Statistical analysis: Data Entry was done using Microsoft excel 2013 and analysis done using SPSS V 16. Qualitative data was expressed in frequencies and percentages and Quantitative data in mean and standard deviation. Parametric tests include Unpaired t test for intergroup comparison was used. Paired t test for intragroup comparison was used. Bar diagrams and pie chart were used to represent the data. p value of <0.05 was considered statistically significant.
Table 1: Age Distribution
|
` AGE IN YEARS |
GROUP A |
GROUP B |
TOTAL |
|||
|
No of pts |
% |
No of pts |
% |
No of pts |
% |
|
|
24-30 yrs |
3 |
12% |
2 |
8% |
5 |
10% |
|
31-40 yrs |
4 |
16% |
6 |
24% |
10 |
20% |
|
41-50 yrs |
9 |
36% |
6 |
24% |
15 |
30% |
|
51-60 yrs |
6 |
24% |
6 |
24% |
12 |
24% |
|
> 60 yrs |
3 |
12% |
5 |
20% |
8 |
16% |
In our study of 50 cases age of the patients ranged from 24-81 yrs with most of the patients in age group of 41-50 yrs (30% N=15, 9 in group A and 6 in group B). The mean age of presentation is 49.18 yrs.
Table 2: Sex incidence
|
Sex |
Group A |
Group B |
Total |
|
No of males |
5 (20%) |
4(16%) |
9(18%) |
|
No of females |
20(80%) |
21(84%) |
41(82%) |
In our study 82% of the patients are females. (N=41, 20 in group A and 21 in group B) and 18% are males (N=9, 5 in group A and 4 in group B).
Table 3: Laterality
|
SIDE |
GROUP A |
GROUP B |
TOTAL |
|||
|
No of pts |
% |
No of pts |
% |
No of pts |
% |
|
|
RIGHT |
11 |
44% |
10 |
40% |
21 |
42% |
|
LEFT |
12 |
48% |
14 |
56% |
26 |
52% |
|
BILATERAL |
2 |
8% |
1 |
4% |
3 |
6% |
In our study 52% of the cases presented with disease on left side. (N= 26, 12 in group A and 14 in group B), 42% (N=21 11 in group A and 12 in group B) had disease on the right side and 6% (N= 3, 2 and1 in group A and group B respectively) had the disease bilaterally.
Table 4: Mode of presentation
|
Diagnosis |
GROUP A |
GROUP B |
TOTAL |
|||
|
No of pts |
% |
No of pts |
% |
No of pts |
% |
|
|
CDC |
21 |
84% |
22 |
88% |
43 |
86% |
|
CDC+ Mucocele |
2 |
8% |
1 |
4% |
3 |
6% |
|
CDC+ Pyocele |
2 |
8% |
2 |
8% |
4 |
8% |
In our study majority of the patients (86%) presented with chronic dacryocystitis and 6% (N=3, 2 in group A ,1 in group B) presented with mucocele and 8 % (N=4, 2 in each group) presented with pyocele. Fishers exact test p=0.999 NS, the presence of pyocele or mucocele did not affect the results.
Table 5: Syringing results at 1st, 6th and 10th week.
|
|
1st week |
6th week |
10th week |
|||
|
Syringing |
Group A |
Group B |
Group A |
Group B |
Group A |
Group B |
|
Patent |
0 |
25(100%) |
24(96%) |
22(88 %) |
23(92%) |
22(88%) |
|
Non patent |
0 |
0 |
1(4%) |
3(12%) |
2(8%) |
3(12%) |
Objective analysis was done by syringing, in group B patients it was found to be patent in all cases N=25 (100%). At 6th week in group B syringing was patent in 88%(N=22) and non-patent in 12%(N=3) of cases. At 10 weeks syringing in group A was patent in 23(92%) and non-patent in 2(8%) of cases. In group B syringing patency was seen in 22 (88%) and was non patent in 3(12%) of the cases.
Table 6: Symptomatic relief
|
|
1st week |
6th week |
10th week |
|||
|
Syringing |
Group A |
Group B |
Group A |
Group B |
Group A |
Group B |
|
Complete relief |
0 |
25(100%) |
24(96%) |
22 (88%) |
23(92%) |
22(88%) |
|
No relief |
0 |
0 |
1(4%) |
3(12%) |
2(8%) |
3(12%) |
At 1st week (table 6), all the cases reported a complete symptomatic relief 100%(N=40). At 6th week,90%(N=36) of cases reported complete relief and 2.5%(N=1) reported partial relief,7.5%(N=3) cases reported no relief of symptoms. At 10th week complete relief from epiphora was reported by 92.5% (N=37) and no relief of symptoms in 7.5%(N=3).
Table 7: Results after 3 months
|
Group |
Objective analysis |
Subjective assessment |
||
|
Patent |
Non patent |
Relieved |
Non-Relieved |
|
|
Group A |
23(92%) |
2(8%) |
23(92%) |
2(8%) |
|
Group B |
22(88%) |
3(12%) |
22(88%) |
3(12%) |
The overall success results at three months (table 7, figure 22) are 88%, closure of the rhinostomal opening was seen in two cases which led to failure and in another patient, there was fibrosis at the rhinostomal opening which led to failure.
Table 8: Complications
|
COMPLICATION |
GROUP A |
GROUP B |
|
None |
18 |
22 |
|
Rhinostomal closure |
1 |
2 |
|
Granulation |
1 |
0 |
|
Irritation |
3 |
0 |
|
Minor post op bleed |
2 |
1 |
There were no major surgical complications (table 8 figure 23) such as orbital injury or diplopia. Closure of the rhinostoma was seen in 3 cases. granulations noted in one patient.no post operative bleeding noted in group B reported any irritation. Spontaneous extrusion of the prolene stent was not seen in any of the cases. In none of the patients was the stent needed to be removed before 6 weeks. The prolene stenting material did not cause either punctual stenosis or canalicular laceration in any of the cases.
During our study no major complications were observed. Minor post operative bleed was seen in two cases of group A and a case of group B. Ocular irritation was complained by 3(12%) of the patients of group A which was managed with steroid eye drops and antibiotics and none of the cases in group B. We observed granulation tissue around prolene in one case. Rhinostomal closure was observed in a case of group A and in two cases of group B. Fibrosis of the stomal opening was seen in a case of group B. Spontaneous extrusion of the prolene stent was not seen in any of the cases. In none of the patients was the stent needed to be removed before 6 weeks. The prolene stenting material did not cause either punctual stenosis or canalicular laceration in any of the cases. Hence prolene can be efficiently used as a stenting material in En DCR.
In this study comparing endoscopic dacryocystorhinostomy (En DCR) with and without prolene stenting in 50 cases of chronic dacryocystitis (with prolene used in 50% of randomly divided cases), we conclude, based on the available data and literature, that En DCR is a simple, safe, and minimally invasive procedure offering direct access to the lacrimal sac, making it suitable even for pyocele and mucocele cases, with the added cosmetic benefit of no external scar. Prolene emerges as an excellent non-absorbable stenting material due to its retention of strength, minimal tissue reactivity, slipperiness for easy removal, resistance to bacterial contamination, and blue dye for intranasal visibility; lateral displacement causing ocular discomfort, conjunctivitis, or corneal erosion can be prevented by tying multiple knots in the nasal cavity. As a cost-effective, readily available option in all operating theaters, prolene serves as an effective alternative to routine silicone stents in resource-limited settings, particularly for primary cases with postsaccal or nasolacrimal duct obstruction. Overall, En DCR demonstrates good success rates with or without stenting.